Page last updated: 2024-11-07

spironolactone and Lipoma

spironolactone has been researched along with Lipoma in 1 studies

Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.

Lipoma: A benign tumor composed of fat cells (ADIPOCYTES). It can be surrounded by a thin layer of connective tissue (encapsulated), or diffuse without the capsule.

Research Excerpts

ExcerptRelevanceReference
"Aldosterone treatment of undifferentiated cells induced accumulation of intracytoplasmic lipid droplets and mitochondria."1.31The mineralocorticoid receptor mediates aldosterone-induced differentiation of T37i cells into brown adipocytes. ( Cluzeaud, F; Le Menuet, D; Lombès, M; Penfornis, P; Viengchareun, S; Zennaro, MC, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Penfornis, P1
Viengchareun, S1
Le Menuet, D1
Cluzeaud, F1
Zennaro, MC1
Lombès, M1

Other Studies

1 other study available for spironolactone and Lipoma

ArticleYear
The mineralocorticoid receptor mediates aldosterone-induced differentiation of T37i cells into brown adipocytes.
    American journal of physiology. Endocrinology and metabolism, 2000, Volume: 279, Issue:2

    Topics: Adipose Tissue, Brown; Aldosterone; Animals; Carrier Proteins; Cell Differentiation; Dose-Response R

2000